INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 79 filers reported holding INSTIL BIO INC in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $11,357 | -8.4% | 17,186 | -12.7% | 0.00% | – |
Q4 2022 | $12,403 | -86.2% | 19,687 | +5.9% | 0.00% | – |
Q3 2022 | $90,000 | +8.4% | 18,582 | +3.9% | 0.00% | – |
Q2 2022 | $83,000 | -66.9% | 17,886 | -23.8% | 0.00% | -100.0% |
Q1 2022 | $251,000 | -51.2% | 23,481 | -21.7% | 0.00% | 0.0% |
Q4 2021 | $514,000 | – | 29,983 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Curative Ventures V LLC | 37,980,073 | $183,824,000 | 100.00% |
CPMG Inc | 8,218,467 | $39,777,000 | 7.80% |
Vivo Capital, LLC | 12,486,787 | $60,436,000 | 6.67% |
VR Adviser, LLC | 4,105,779 | $19,872,000 | 3.07% |
Samsara BioCapital, LLC | 1,788,280 | $8,655,000 | 2.02% |
Parametrica Management Ltd | 88,263 | $428,000 | 0.88% |
RA Capital Management | 7,670,793 | $37,127,000 | 0.79% |
Fairmount Funds Management LLC | 673,905 | $3,262,000 | 0.57% |
Nicholas Investment Partners, LP | 897,386 | $4,343,000 | 0.40% |
Logos Global Management LP | 331,872 | $1,606,000 | 0.20% |